Literature DB >> 7487900

Agonists for endothelial P2 purinoceptors trigger a signalling pathway producing Ca2+ responses in lymphocytes adherent to endothelial cells.

J S Wiley1, J R Chen, G P Jamieson, P J Thurlow.   

Abstract

Recirculation of lymphocytes through the body involves their frequent adhesion to endothelial cells but little is known of the signalling pathways between these two cell types. Lymphocytes from patients with chronic lymphocytic leukaemia were loaded with the Ca(2+)-sensitive indicator, fura 2, and allowed to adhere to either glass or monolayers of human umbilical-vein endothelial cells. Addition of ATP or UTP (1-10 microM) to the superfusate produced a transient rise in cytosolic Ca2+ concentration in the lymphocytes adherent to endothelium (24 of 35 cells). In contrast, ATP or UTP (1-10 microM) had no effect on the cytosolic Ca2+ of lymphocytes attached to glass. As the only lymphocyte receptor for ATP (P2Z class) requires higher ATP concentrations ( > 50 microM) for Ca2+ influx and is unresponsive to UTP, the involvement of a lymphocyte P2Z purinoceptor is unlikely. Various agonists including ATP, UTP, 2-methylthioATP, ADP and histamine all stimulated increases in endothelial cytosolic Ca2+ but only ATP and UTP (both agonists for endothelial P2U purinoceptors) triggered Ca2+ transients in adherent lymphocytes. Removal of extracellular Ca2+ did not abolish the ATP-induced rise in cytosolic Ca2+ concentration in lymphocytes adherent to endothelial cells. These findings show that stimulation of endothelial P2U purinoceptors triggers an endothelial-lymphocyte signalling pathway which releases internal Ca2+ in adherent lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487900      PMCID: PMC1136040          DOI: 10.1042/bj3110589

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Synchronized repetitive spikes in cytoplasmic calcium in confluent monolayers of human umbilical vein endothelial cells.

Authors:  C B Neylon; R F Irvine
Journal:  FEBS Lett       Date:  1990-11-26       Impact factor: 4.124

Review 2.  Stimulus-secretion coupling in vascular endothelial cells.

Authors:  A C Newby; A H Henderson
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

Review 3.  Overview. Purinergic mechanisms.

Authors:  G Burnstock
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Influx of bivalent cations can be independent of receptor stimulation in human endothelial cells.

Authors:  T J Hallam; R Jacob; J E Merritt
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 5.  P2 purinoceptors on vascular endothelial cells: physiological significance and transduction mechanisms.

Authors:  J M Boeynaems; J D Pearson
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

6.  Regulation of P2y-purinoceptor-mediated prostacyclin release from human endothelial cells by cytoplasmic calcium concentration.

Authors:  T D Carter; T J Hallam; N J Cusack; J D Pearson
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

7.  The [Ca2+]i increase induced in murine thymocytes by extracellular ATP does not involve ATP hydrolysis and is not related to phosphoinositide metabolism.

Authors:  C el-Moatassim; T Maurice; J C Mani; J Dornand
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

8.  Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel.

Authors:  P Pizzo; P Zanovello; V Bronte; F Di Virgilio
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

9.  Extracellular ATP stimulates an amiloride-sensitive sodium influx in human lymphocytes.

Authors:  J S Wiley; G P Jamieson; W Mayger; E J Cragoe; M Jopson
Journal:  Arch Biochem Biophys       Date:  1990-08-01       Impact factor: 4.013

10.  IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils.

Authors:  M H Thornhill; U Kyan-Aung; D O Haskard
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.